Skip to main content
. Author manuscript; available in PMC: 2016 Jul 28.
Published in final edited form as: Mol Pharm. 2016 Jun 8;13(7):2524–2530. doi: 10.1021/acs.molpharmaceut.6b00248

Figure 1.

Figure 1

Study design. Gene expression data from LINCS Project was linked to 12 MeSH therapeutic use categories. DNN was trained separately on gene expression level data for “landmark genes” and pathway activation scores for significantly perturbed samples, forming an input layers of 977 and 271 neural nodes, respectively.

OSZAR »